DNA Repair Drugs Market 2027 by Type, Application | The Insight Partners

DNA Repair Drugs Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Type (PARP Inhibitors, Other); Application (Oncological, Stroke)

Report Code: TIPRE00008173 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

DNA repair is a collection of processes by which a cell recognizes and corrects damage to the DNA molecules that encode its genome. DNA repair drugs are used in repairing damaged DNA and for treating cancers. DNA damage results in genetic disorders; however, the human body has its mechanisms to correct the DNA sequence. DNA repair drugs such as PARP inhibitors and other DNA repair drugs help to treat diseases with genetic aberrations.

MARKET DYNAMICS

The DNA repair drugs market is anticipated to grow, owing to increasing collaboration and acquisition activities. Moreover, frequent research and development activities are expected to benefit the growth of the market in the forecast period.

MARKET SCOPE

The "DNA Repair Drugs Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of in DNA repair drugs market with detailed market segmentation by type, application and geography. The DNA repair drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in DNA repair drugs market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The DNA repair drugs market is segmented on the basis of type and application. Based on type the market is segmented as PARP inhibitors and other. On the basis of application the market is categorized as oncological and stroke.



Get more information on this report :

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in DNA repair drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The DNA repair drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting DNA repair drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the DNA repair drugs market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the in DNA repair drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in DNA repair drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for in DNA repair drugs market in the global market. Below mentioned is the list of few companies engaged in the DNA repair drugs market.

The report also includes the profiles of key in DNA repair drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  4SC AG
  •  Bristol Myers Squibb
  •  British Columbia Cancer Agency
  •  Cambridge University Hospitals NHS Foundation Trust
  •  Genentech
  •  Jiangsu Hengrui Medicine
  •  Johnson & Johnson
  •  Jonsson Comprehensive Cancer Center
  •  Karyopharm Therapeutics
  •  TESARO, Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 DNA Repair Drugs Market - By Type
1.3.2 DNA Repair Drugs Market - By Application
1.3.3 DNA Repair Drugs Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS


3. RESEARCH METHODOLOGY


4. DNA REPAIR DRUGS MARKET LANDSCAPE

4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DNA REPAIR DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC

6. DNA REPAIR DRUGS MARKET - GLOBAL MARKET ANALYSIS

6.1. DNA REPAIR DRUGS - GLOBAL MARKET OVERVIEW
6.2. DNA REPAIR DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. DNA REPAIR DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE

7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. PARP INHIBITORS
7.3.1. Overview
7.3.2. PARP Inhibitors Market Forecast and Analysis
7.4. OTHER
7.4.1. Overview
7.4.2. Other Market Forecast and Analysis

8. DNA REPAIR DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION

8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. ONCOLOGICAL
8.3.1. Overview
8.3.2. Oncological Market Forecast and Analysis
8.4. STROKE
8.4.1. Overview
8.4.2. Stroke Market Forecast and Analysis

9. DNA REPAIR DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

9.1. NORTH AMERICA
9.1.1 North America DNA Repair Drugs Market Overview
9.1.2 North America DNA Repair Drugs Market Forecasts and Analysis
9.1.3 North America DNA Repair Drugs Market Forecasts and Analysis - By Type
9.1.4 North America DNA Repair Drugs Market Forecasts and Analysis - By Application
9.1.5 North America DNA Repair Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States DNA Repair Drugs Market
9.1.5.1.1 United States DNA Repair Drugs Market by Type
9.1.5.1.2 United States DNA Repair Drugs Market by Application
9.1.5.2 Canada DNA Repair Drugs Market
9.1.5.2.1 Canada DNA Repair Drugs Market by Type
9.1.5.2.2 Canada DNA Repair Drugs Market by Application
9.1.5.3 Mexico DNA Repair Drugs Market
9.1.5.3.1 Mexico DNA Repair Drugs Market by Type
9.1.5.3.2 Mexico DNA Repair Drugs Market by Application
9.2. EUROPE
9.2.1 Europe DNA Repair Drugs Market Overview
9.2.2 Europe DNA Repair Drugs Market Forecasts and Analysis
9.2.3 Europe DNA Repair Drugs Market Forecasts and Analysis - By Type
9.2.4 Europe DNA Repair Drugs Market Forecasts and Analysis - By Application
9.2.5 Europe DNA Repair Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany DNA Repair Drugs Market
9.2.5.1.1 Germany DNA Repair Drugs Market by Type
9.2.5.1.2 Germany DNA Repair Drugs Market by Application
9.2.5.2 France DNA Repair Drugs Market
9.2.5.2.1 France DNA Repair Drugs Market by Type
9.2.5.2.2 France DNA Repair Drugs Market by Application
9.2.5.3 Italy DNA Repair Drugs Market
9.2.5.3.1 Italy DNA Repair Drugs Market by Type
9.2.5.3.2 Italy DNA Repair Drugs Market by Application
9.2.5.4 Spain DNA Repair Drugs Market
9.2.5.4.1 Spain DNA Repair Drugs Market by Type
9.2.5.4.2 Spain DNA Repair Drugs Market by Application
9.2.5.5 United Kingdom DNA Repair Drugs Market
9.2.5.5.1 United Kingdom DNA Repair Drugs Market by Type
9.2.5.5.2 United Kingdom DNA Repair Drugs Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific DNA Repair Drugs Market Overview
9.3.2 Asia-Pacific DNA Repair Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific DNA Repair Drugs Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific DNA Repair Drugs Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific DNA Repair Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia DNA Repair Drugs Market
9.3.5.1.1 Australia DNA Repair Drugs Market by Type
9.3.5.1.2 Australia DNA Repair Drugs Market by Application
9.3.5.2 China DNA Repair Drugs Market
9.3.5.2.1 China DNA Repair Drugs Market by Type
9.3.5.2.2 China DNA Repair Drugs Market by Application
9.3.5.3 India DNA Repair Drugs Market
9.3.5.3.1 India DNA Repair Drugs Market by Type
9.3.5.3.2 India DNA Repair Drugs Market by Application
9.3.5.4 Japan DNA Repair Drugs Market
9.3.5.4.1 Japan DNA Repair Drugs Market by Type
9.3.5.4.2 Japan DNA Repair Drugs Market by Application
9.3.5.5 South Korea DNA Repair Drugs Market
9.3.5.5.1 South Korea DNA Repair Drugs Market by Type
9.3.5.5.2 South Korea DNA Repair Drugs Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa DNA Repair Drugs Market Overview
9.4.2 Middle East and Africa DNA Repair Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa DNA Repair Drugs Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa DNA Repair Drugs Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa DNA Repair Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa DNA Repair Drugs Market
9.4.5.1.1 South Africa DNA Repair Drugs Market by Type
9.4.5.1.2 South Africa DNA Repair Drugs Market by Application
9.4.5.2 Saudi Arabia DNA Repair Drugs Market
9.4.5.2.1 Saudi Arabia DNA Repair Drugs Market by Type
9.4.5.2.2 Saudi Arabia DNA Repair Drugs Market by Application
9.4.5.3 U.A.E DNA Repair Drugs Market
9.4.5.3.1 U.A.E DNA Repair Drugs Market by Type
9.4.5.3.2 U.A.E DNA Repair Drugs Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America DNA Repair Drugs Market Overview
9.5.2 South and Central America DNA Repair Drugs Market Forecasts and Analysis
9.5.3 South and Central America DNA Repair Drugs Market Forecasts and Analysis - By Type
9.5.4 South and Central America DNA Repair Drugs Market Forecasts and Analysis - By Application
9.5.5 South and Central America DNA Repair Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil DNA Repair Drugs Market
9.5.5.1.1 Brazil DNA Repair Drugs Market by Type
9.5.5.1.2 Brazil DNA Repair Drugs Market by Application
9.5.5.2 Argentina DNA Repair Drugs Market
9.5.5.2.1 Argentina DNA Repair Drugs Market by Type
9.5.5.2.2 Argentina DNA Repair Drugs Market by Application

10. INDUSTRY LANDSCAPE

10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. DNA REPAIR DRUGS MARKET, KEY COMPANY PROFILES
11.1. 4SC AG
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BRISTOL MYERS SQUIBB
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BRITISH COLUMBIA CANCER AGENCY
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. GENENTECH
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. JIANGSU HENGRUI MEDICINE
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. JOHNSON AND JOHNSON
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. JONSSON COMPREHENSIVE CANCER CENTER
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. KARYOPHARM THERAPEUTICS
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. TESARO, INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX

12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. 4SC AG
2. Bristol Myers Squibb
3. British Columbia Cancer Agency
4. Cambridge University Hospitals NHS Foundation Trust
5. Genentech
6. Jiangsu Hengrui Medicine
7. Johnson & Johnson
8. Jonsson Comprehensive Cancer Center
9. Karyopharm Therapeutics
10. TESARO, Inc.
TIPRE00008173
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking